Up-regulated expression of cartilage intermediate-layer protein and ANK in articular hyaline cartilage from patients with calcium pyrophosphate dihydrate crystal deposition disease

Arthritis and Rheumatism

Volumn 46, Issue 12, 2002, Pages 3218-3229

  Hirose, Jun ^a   Ryan, Lawrence M ^a   Masuda, Ikuko ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM PYROPHOSPHATE; CARTILAGE INTERMEDIATE PROTEIN; CELL MEMBRANE PROTEIN; GLYCOPROTEIN; HYALIN; MESSENGER RNA; PLASMA CELL MEMBRANE GLYCOPROTEIN 1; PROTEIN ANK; PYROPHOSPHATE; SOMATOMEDIN C; TISSUE EXTRACT; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTHROPLASTY; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE CELL; CELL CULTURE; CONTROLLED STUDY; CRYSTAL; CULTURE MEDIUM; HUMAN; HUMAN CELL; IMMUNOBLOTTING; OSTEOARTHRITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; AGED; CARTILAGE, ARTICULAR; CHONDROCALCINOSIS; CHONDROCYTES; DIPHOSPHATES; EXTRACELLULAR MATRIX PROTEINS; EXTRACELLULAR SPACE; GROWTH SUBSTANCES; HUMANS; HYALIN; MEMBRANE PROTEINS; MIDDLE AGED; OSTEOARTHRITIS; PHOSPHATE TRANSPORT PROTEINS; PYROPHOSPHATASES; UP-REGULATION;

EID: 0036899815     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10632     Document Type: Article

References (68)

1. Wilkins E, Dieppe P, Maddison P, Evison G. Osteoarthritis and articular chondrocalcinosis in the elderly. Ann Rheum Dis 1983; 42:280-4.
2. Ryan LM, McCarty DJ. Calcium pyrophosphate crystal deposition disease, pseudogout, and articular chondrocalcinosis. In: Koopman WJ, editor. Arthritis and Allied Conditions. 13th Ed. Baltimore: Williams and Wilkins; 1997. p. 2103-25.
3. Cheung HS, Ryan LM. Role of crystal deposition in matrix degradation. In: Woessner FJ, Howell DS, editors. Joint cartilage degradation: basic and clinical aspects. New York: Marcel Dekker; 1995. p. 209-23.
4. Russell RG, Bisaz S, Fleisch H, Currey HL, Rubinstein HM, Dietz AA, et al. Inorganic pyrophosphate in plasma, urine, and synovial fluid of patients with pyrophosphate arthropathy (chondrocalcinosis or pseudogout). Lancet 1970;2:899-902.
5. McCarty DJ, Solomon SD, Warnock ML, Paloyan E. Inorganic pyrophosphate concentrations in the synovial fluid of arthritic patients. J Lab Clin Med 1971;78:216-29.
6. Altman RD, Muniz OE, Pita JC, Howell DS. Articular chondrocalcinosis. Microanalysis of pyrophosphate (PPi) in synovial fluid and plasma. Arthritis Rheum 1973;16:171-8.
7. Silcox DC, McCarty DJ. Elevated inorganic pyrophosphate concentrations in synovial fluids in osteoarthritis and pseudogout. J Lab Clin Med 1974;83:518-31.
8. Rachow JW, Ryan LM. Adenosine triphosphate pyrophosphohydrolase and neutral inorganic pyrophosphatase in pathologic joint fluids: Elevated pyrophosphohydrolase in calcium pyrophosphate dihydrate crystal deposition disease. Arthritis Rheum 1985;28: 1283-8.
9. Rachow JW, Ryan LM, McCarty DJ, Halverson PC. Synovial fluid inorganic pyrophosphate concentration and nucleotide pyrophosphohydrolase activity in basic calcium phosphate deposition arthropathy and Milwaukee shoulder syndrome. Arthritis Rheum 1988; 31:408-13.
10. Ryan LM, Rachow JW, McCarty DJ. Synovial fluid ATP: A potential substrate for the production of inorganic pyrophosphate. J Rheumatol 1991;18:716-20.
11. Rosenthal AK, McCarty BA, Cheung HS, Ryan LM. A comparison of the effect of transforming growth factor β1 on pyrophosphate elaboration from various articular tissues. Arthritis Rheum 1993;36:539-42.
12. Derfus BA, Rachow JW, Mandel NS, Boskey AL, Buday M, Kushnaryov VM, et al. Articular cartilage vesicles generate calcium pyrophosphate dihydrate-like crystals in vitro. Arthritis Rheum 1992;35:231-40.
13. Rachow JW, Ryan LM. Inorganic pyrophosphate metabolism in arthritis. Rheum Dis Clin North Am 1988;14:289-302.
14. Felix R, Fleisch H. The effect of pyrophosphate and diphosphonates on calcium transport in red cells. Experientia 1977;33: 1003-5.
15. Ryan LM, Wortmann RL, Karas B, McCarty DJ Jr. Cartilage nucleoside triphosphate pyrophosphohydrolase. II. Role in extracellular pyrophosphate generation and nucleotide metabolism. Arthritis Rheum 1985;28:413-8.
16. Masuda I, Ryan LM, McCarty DJ. Inorganic pyrophosphate metabolism. In: Smyth CJ, Holers VM, editors. Gout, Hyperuricemia, and Other Crystal-Associated Arthropathies. New York: Marcel Dekker; 1999. p. 359-67.
17. Howell DS, Martel-Pelletier J, Pelletier J-P, Morales S, Muniz O. NTP pyrophosphohydrolase in human chondrocalcinotic and osteoarthritic cartilage. II. Further studies on histologic and subcellular distribution. Arthritis Rheum 1984;27:193-9.
18. Park W, Masuda I, Cardenal EA, Palmer DL, McCarty DJ. Inorganic pyrophosphate generation from adenosine triphosphate by cell-free human synovial fluid. J Rheumatol 1996;23:665-71.
19. Ryan LM, Wortmann RL, Karas B, McCarty DJ Jr. Cartilage nucleoside triphosphate (NTP) pyrophosphohydrolase. I. Identification as an ecto-enzyme. Arthritis Rheum 1984;27:404-9.
20. Johnson K, Jung A, Murphy A, Andreyev A, Dykens J, Terkeltaub R. Mitochondrial oxidative phosphorylation is a downstream regulator of nitric oxide effects on chondrocyte matrix synthesis and mineralization. Arthritis Rheum 2000;43:1560-70.
21. Lorenzo P, Neame P, Sommarin Y, Heinegard D. Cloning and deduced amino acid sequence of a novel cartilage protein (CILP) identifies a proform including a nucleotide pyrophosphohydrolase. J Biol Chem 1998;273:23469-75.
22. Masuda I, Halligan BD, Barbieri JT, Haas AL, Ryan LM, McCarty DJ. Molecular cloning and expression of a porcine chondrocyte nucleotide pyrophosphohydrolase. Gene 1997;197:277-87.
23. Cardenal A, Masuda I, Haas AL, McCarty DJ. Specificity of a porcine 127-kd nucleotide pyrophosphohydrolase for articular tissues. Arthritis Rheum 1996;39:245-51.
24. Masuda I, Cardenal A, Ono W, Hamada J, Haas AL, McCarty DJ. Nucleotide pyrophosphohydrolase in human synovial fluid. J Rheumatol 1997;24:1588-94.
25. Masuda I, Hamada J, Haas AL, Ryan LM, McCarty DJ. A unique ectonucleotide pyrophosphohydrolase associated with porcine chondrocyte-derived vesicles. J Clin Invest 1995;95:699-704.
26. Hirose J, Masuda I, Ryan LM. Expression of cartilage intermediate-layer protein/nucleotide pyrophosphohydrolase parallels the production of extracellular inorganic pyrophosphate in response to growth factors and with aging. Arthritis Rheum 2000;43:2703-11.
27. Lorenzo P, Bayliss MT, Heinegard D. A novel cartilage protein (CILP) present in the mid-zone of human articular cartilage increases with age. J Biol Chem 1998;273:23463-8.
28. Masuda I, Iyama KI, Halligan BD, Barbieri JT, Haas AL, McCarty DJ, et al. Variations in site and levels of expression of chondrocyte nucleotide pyrophosphohydrolase with aging. J Bone Miner Res 2001;16:868-75.
29. Goding JW, Terkeltaub R, Maurice M, Deterre P, Sali A, Belli SI. Ecto-phosphodiesterase/pyrophosphatase of lymphocytes and non-lymphoid cells: Structure and function of the PC-1 family. Immunol Rev 1998;161:11-26.
30. Huang R, Rosenbach M, Vaughn R, Provvedini D, Rebbe N, Hickman S, et al. Expression of the murine plasma cell nucleotide pyrophosphohydrolase PC-1 is shared by human liver, bone, and cartilage cells: Regulation of PC-1 expression in osteosarcoma cells by transforming growth factor-beta. J Clin Invest 1994;94:560-7.
31. Terkeltaub R, Rosenbach M, Fong F, Goding J. Causal link between nucleotide pyrophosphohydrolase overactivity and increased intracellular inorganic pyrophosphate generation demonstrated by transfection of cultured fibroblasts and osteoblasts with plasma cell membrane glycoprotein-1 relevance to calcium pyrophosphate dihydrate deposition disease. Arthritis Rheum 1994;37: 934-41.
32. Johnson K, Moffa A, Chen Y, Pritzker K, Goding J, Terkeltaub R. Matrix vesicle plasma cell membrane glycoprotein-1 regulates mineralization by murine osteoblastic MC3T3 cells. J Bone Miner Res 1999;14:883-92.
33. Ho AM, Johnson MD, Kingsley DM. Role of the mouse ank gene in control of tissue calcification and arthritis. Science 2000;289: 265-70.
34. Rosenthal AK, Ryan LM. Probenecid inhibits transforming growth factor-beta 1 induced pyrophosphate elaboration by chondrocytes. J Rheumatol 1994;21:896-900.
35. Rosenthal AK, Cheung HS, Ryan LM. Transforming growth factor β1 stimulates inorganic pyrophosphate elaboration by porcine cartilage. Arthritis Rheum 1991;34:904-11.
36. Rosenthal AK, Ryan LM. Ageing increases growth factor-induced inorganic pyrophosphate elaboration by articular cartilage. Mech Ageing Dev 1994;75:35-44.
37. Olmez U, Ryan LM, Kurup IV, Rosenthal AK. Insulin-like growth factor-1 suppresses pyrophosphate elaboration by transforming growth factor beta 1-stimulated chondrocytes and cartilage. Osteoarthritis Cartilage 1994;2:149-54.
38. Cheung HS, Ryan LM. A method for determining DNA and chondrocyte content of articular cartilage. Anal Biochem 1981; 116:93-7.
39. Goldring MB, Berenbaum F. Human chondrocyte cultures as models of cartilage-specific gene regulation. In: Jones GE, editor. Human Cell Culture Protocols. Totowa (NJ): Humana Press; 1996. p. 217-32.
40. Bluteau G, Labourdette L, Ronziere M, Conrozier T, Mathieu P, Herbage D, et al. Type X collagen in rabbit and human meniscus. Osteoarthritis Cartilage 1999;7:498-501.
41. Loeser RF, Sadiev S, Tan L, Goldring MB. Integrin expression by primary and immortalized human chondrocytes: Evidence of a differential role for alpha1beta1 and alpha2beta1 integrins in mediating chondrocyte adhesion to types II and VI collagen. Osteoarthritis Cartilage 2000;8:96-105.
42. Rachow JW, Ryan LM. Partial characterization of synovial fluid nucleotide pyrophosphohydrolase. Arthritis Rheum 1985;28: 1377-83.
43. Lowry OH, Rosebrough AL, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193:265-75.
44. Funakoshi I, Kato H, Horie K, Yano T, Hori Y, Kobayashi H, et al. Molecular cloning of cDNAs for human fibroblast nucleotide pyrophosphatase. Arch Biochem Biophys 1992;295:180-7.
45. Reichenberger E, Tiziani V, Watanabe S, Park L, Ueki Y, Santanna C, et al. Autosomal dominant craniometaphyseal dysplasia is caused by mutations in the transmembrane protein ANK. Am J Hum Genet 2001;68:1321-6.
46. Strehlau J, Pavlakis M, Lipman M, Shapiro M, Vasconcellos L, Harmon W, et al. Quantitative detection of immune activation transcripts as a diagnostic tool in kidney transplantation. Proc Natl Acad Sci U S A 1997;94:695-700.
47. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci U S A 1977;74:5463-7.
48. Lust G, Nuki G, Seegmiller JE. Inorganic pyrophosphate and proteoglycan metabolism in cultured human articular chondrocytes and fibroblasts. Arthritis Rheum 1976;19:479-87.
49. Ryan LM, Wortmann RL, Karas B, Lynch MP, McCarty DJ. Pyrophosphohydrolase activity and inorganic pyrophosphate content of cultured human skin fibroblasts: Elevated levels in some patients with calcium pyrophosphate dihydrate deposition disease. J Clin Invest 1986;77:1689-93.
50. Hamilton E, Pattrick M, Doherty M. Inorganic pyrophosphate, nucleoside triphosphate pyrophosphatase, and cartilage fragments in normal human synovial fluid. Br J Rheumatol 1991;30:260-4.
51. Doherty M, Hamilton E, Henderson J, Misra H, Dixey J. Familial chondrocalcinosis due to calcium pyrophosphate dihydrate crystal deposition in English families. Br J Rheumatol 1991;30:10-5.
52. Tenenbaum J, Muniz O, Schumacher HR, Good AE, Howell DS. Comparison of phosphohydrolase activities from articular cartilage in calcium pyrophosphate deposition disease and primary osteoarthritis. Arthritis Rheum 1981;24:492-500.
53. Muniz O, Pelletier J-P, Martel -Pelletier J, Morales S, Howell DS. NTP pyrophosphohydrolase in human chondrocalcinotic and osteoarthritic cartilage. I. Some biochemical characteristics. Arthritis Rheum 1984;27:186-92.
54. Fang PK, Ma XC, Ma DL, Fu KY. Determination of interleukin-1 receptor antagonist, interleukin-10, and transforming growth factor-beta1 in synovial fluid aspirates of patients with temporomandibular disorders. J Oral Maxillofac Surg 1999;57:922-8.
55. Kanety H, Shimon I, Ehrenfeld M, Israeli A, Pariente C, Karasik A. Insulin-like growth factor I and its binding proteins 3 and 4 are increased in human inflammatory synovial fluid. J Rheumatol 1996;23:815-8.
56. Matsumoto T, Gargosky SE, Iwasaki K, Rosenfeld RG. Identification and characterization of insulin-like growth factors (IGFs), IGF-binding proteins (IGFBPs), and IGFBP proteases in human synovial fluid. J Clin Endocrinol Metab 1996;81:150-5.
57. Schneiderman R, Rosenberg N, Hiss J, Lee P, Liu F, Hintz RL, et al. Concentration and size distribution of insulin-like growth factor-I in human normal and osteoarthritic synovial fluid and cartilage. Arch Biochem Biophys 1995;324:173-88.
58. Okawa A, Nakamura I, Goto S, Moriya H, Nakamura Y, Ikegawa S. Mutation in Npps in a mouse model of ossification of the posterior longitudinal ligament of the spine. Nat Genet 1998;19: 271-3.
59. Rutsch F, Vaingankar S, Johnson K, Goldfine I, Maddux B, Schauerte P, et al. PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. Am J Pathol 2001;158:543-54.
60. Johnson K, Hashimoto S, Lotz M, Pritzker K, Goding J, Terkeltaub R. Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification. Arthritis Rheum 2001;44:1071-81.
61. Yamakawa K, Iwasaki H, Masuda I, Ohjimi Y, Honda I, Shono E, et al. Cartilage intermediate layer protein expression in calcium pyrophosphate dihydrate crystal deposition disease. J Rheumatol 2002;29:1746-53.
62. Johnson K, Etten DV, Terkeltaub R. ANK and PC-1 regulate cartilage matrix calcification by synergistically controlling extracellular PPi [abstract]. Arthritis Rheum 2001;44 Suppl 9:S162.
63. Pendleton A, Johnston M, Ho A, Gurley K, Kingsley D, Wright GD, et al. A heterozygous mutation in the human ANK gene in a British family with adult onset chondrocalcinosis due to calcium pyrophosphate crystal deposition [abstract]. Arthritis Rheum 2001;44 Suppl 9:S101.
64. Johnston M, Ho A, McGrath R, Netter P, Loeuille D, Gillet P, et al. Analysis of the ANK gene reveals a heterozygous missense mutation in a French family with calcium pyrophosphate deposition disease (CPPDD) [abstract]. Arthritis Rheum 2001;44 Suppl 9:S161.
65. Marinescu RC, Nyce K, Serrano de la Peña L, Overhauser J, Williams CJ. Exclusion of the gene for human cartilage intermediate layer protein in currently mapped calcium pyrophosphate dihydrate deposition syndromes. Arthritis Rheum 1999;42: 2139-44.
66. Lotz M, Rosen F, McCabe G, Quach J, Blanco F, Dudler J, et al. Interleukin 1 beta suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes. Proc Natl Acad Sci U S A 1995;92:10364-8.
67. Sola B, Salaun V, Ballet JJ, Troussard X. Transcriptional and post-transcriptional mechanisms induce cyclin-D1 over-expression in B-chronic lymphoproliferative disorders. Int J Cancer 1999;83:230-4.
68. Labow BI, Souba WW, Abcouwer SF. Glutamine synthetase expression in muscle is regulated by transcriptional and posttranscriptional mechanisms. Am J Physiol 1999;276:E1136-45.